Streetbeat News

Products Services

JNJ

Johnson & Johnson's CFO, Wolk, anticipates a potential drop in European sales of Stelara starting mid-2024, but overall Stelara sales should remain stable. The company's ex-US sales in the Pharma unit have been impacted by falling demand for its Covid-19 vaccine.

Portfolio Pulse from Charles Gross

October 17, 2023 | 11:36 am

AAPL

Apple Inc. is preparing to launch the iPad mini 7, which is expected to feature three major upgrades and several new color options. The upgrades include a new A16 Bionic chipset, upgraded camera hardware and software, and a fix for the 'jelly scrolling' effect. The iPad mini 7 will also come in several new color options.

Portfolio Pulse from Rounak Jain

October 17, 2023 | 11:16 am

GFAI

Guardforce AI (GFAI) has secured a three-year contract with an undisclosed Japanese retailer for its end-to-end cash management solution. The financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 11:05 am

PEV

Phoenix Motor Inc. (NASDAQ:PEV) has partnered with Fermata Energy LLC to successfully integrate Vehicle-to-Grid (V2G) capabilities for all medium-duty electric vehicles manufactured by Phoenix Motorcars. This partnership enables Phoenix to offer V2G capabilities to all bus and truck customers.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 11:05 am

NKTX

Nkarta has received FDA clearance for its Investigational New Drug (IND) application for NKX019 in Lupus Nephritis. This allows the company to proceed with clinical trials.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 11:05 am

BOLT

Bolt Biotherapeutics has announced that the first patient has been dosed in a Phase 1/2 study of BDC-3042, a treatment for advanced cancers.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 11:04 am

APLS

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) and Sobi announced positive results from the Phase 2 NOBLE study investigating pegcetacoplan for the treatment of post-transplant recurrence of primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) and C3 glomerulopathy (C3G). The results will be presented at the American Society of Nephrology (ASN) Kidney Week Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 11:04 am

NKTX

Nkarta has received FDA clearance for its Investigational New Drug (IND) application for NKX019 in Lupus Nephritis. This approval allows Nkarta to proceed with clinical trials.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 11:03 am

ALGM

BMWYY

Allegro MicroSystems (ALGM) and BMW Group (BMWYY) have announced a collaboration to develop high-efficiency traction inverters for battery electric vehicles. The partnership aims to improve the efficiency and performance of electric vehicles.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 11:01 am

EVLO

Evelo Biosciences has reported top-line results from its Phase 2 clinical study with EDP2939 in moderate psoriasis. The primary endpoint was not achieved.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 11:01 am